What is BofA Securities's price target for DAWN?

BofA Securities's latest stated price target for Day One Biopharmaceuticals Inc. (DAWN) is $24, from its action on Aug 1, 2024.

What is BofA Securities's rating on DAWN?

BofA Securities rates DAWN Buy, a bullish rating, as of Aug 1, 2024.

When did BofA Securities last change its view on DAWN?

On Aug 1, 2024, BofA Securities upgrades to Buy from Underperform, price target $11 to $24.

Analyst firms · BofA Securities · DAWN

BofA Securities DAWN price target and rating history

Day One Biopharmaceuticals Inc. (DAWN) · Health Care

BofA Securities rates Day One Biopharmaceuticals Inc. (DAWN) Buy with a $24 price target, as of its latest action on Aug 1, 2024. It has published 3 rating actions on DAWN since December 2022, including 1 upgrade and 1 downgrade.

Current rating: Buy
Price target: $24
Median target, all firms: Too few
Actions on DAWN: 3

BofA Securities price target on DAWN

BofA Securities price target on DAWN, each point a stated target, December 2022 to August 2024.

Every BofA Securities rating on DAWN

Aug 1, 2024
UpgradeBofA Securities upgrades to Buy from Underperform, price target $11 to $24
Apr 25, 2023
DowngradeBofA Securities downgrades to Underperform from Buy, price target $34 to $9
Dec 1, 2022
InitiateBofA Securities starts coverage at Buy, price target $34

How other firms rate DAWN

Each firm's latest rating and stated target in the last 12 months.

Firm	Rating	Price target	Date
H.C. Wainwright	Neutral	$21.50	Mar 10, 2026
TD Cowen	Buy	$34	Jan 13, 2026

Questions about BofA Securities and DAWN

What is BofA Securities's price target for DAWN?: BofA Securities's latest stated price target for Day One Biopharmaceuticals Inc. (DAWN) is $24, from its action on Aug 1, 2024.
What is BofA Securities's rating on DAWN?: BofA Securities rates DAWN Buy, a bullish rating, as of Aug 1, 2024.
When did BofA Securities last change its view on DAWN?: On Aug 1, 2024, BofA Securities upgrades to Buy from Underperform, price target $11 to $24.

More DAWN rating histories

Needham3

All BofA Securities ratings DAWN news and filings Every analyst firm

From rating actions in the Quantisnow feed. A target holds until the firm states a new one; a reiteration with no target keeps the last one. Not investment advice.